CRISPR gene editing for sickle cell disease: one disease, differentiated approaches

Published: 5 August 2021
Editorial
Lisa A Michaels, MD,
Lisa A Michaels, MD
Chief Medical Officer, Editas Medicine
Bruce E Eaton, PhD
Bruce E Eaton, PhD
Chief Business Officer, Editas Medicine

Lisa A Michaels, MD

Chief Medical Officer, Editas Medicine

Bruce E Eaton, PhD

Chief Business Officer, Editas Medicine

Read now